Ticker
ADAPCompany Name
ADAPTIMMUNE THERAPEUTICS PLCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Net Cash Flow - Operations | Operating Cash Flow Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -190.03M | -291.97% | $ 65.08M |
3/31/2025 | $ -107.85M | -60.04% | $ 179.64M |
12/31/2024 | $ -73.21M | -41.12% | $ 178.03M |
9/30/2024 | $ -53.68M | -30.67% | $ 175.04M |
6/30/2024 | $ -44.39M | -31.38% | $ 141.46M |
3/31/2024 | $ -135.55M | -738.35% | $ 18.36M |
12/31/2023 | $ -140.88M | -233.71% | $ 60.28M |
9/30/2023 | $ -124.16M | -174.68% | $ 71.08M |
6/30/2023 | $ -127.16M | -179.69% | $ 70.77M |
3/31/2023 | $ -124.65M | -175.14% | $ 71.17M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Operations / Revenues
(=) OCF %
OCF % for ADAPTIMMUNE THERAPEUTICS PLC is calculated as follows: CF - Operations [ $ -36.9M ] / Revenues [ $ 3.18M ]
(=) OCF % [ -1159.01% ]
Minimum
Mar 31, 2021
Maximum
Dec 31, 2021
Average
Median
filtered constituents | 3.25K |
---|---|
min | -57.27% |
max | 77.08% |
average | 14.31% |
median | 12.65% |
std | 21.13% |